Related Posts

• 
  2018 ISCTM Distinguished Poster Award Winner: “Global Regulatory Agencies Support Dopamine Transporter Neuroimaging in Clinical Trials Targeting Parkinson’s disease”
• 
  Model-Informed Biomarker Qualification: Alzheimer and Parkinson Disease Imaging Biomarkers
• 
  The FDA is Listening: Integrating the Voice of the Patient in Drug Development for Parkinson’s and Huntington’s Diseases
• 
  The Critical Path for Parkinson’s Consortium: Understanding Motor Disease Progression Through Quantitative Medicine
• 
  Global Regulatory Agencies Support the Use of Dopamine Transporter Neuroimaging for Subject Selection in Clinical Trials Targeting Early Stage Parkinson’s Disease